This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, G. A.
Right arrow Articles by Duncan, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, G. A.
Right arrow Articles by Duncan, K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 10 1995, 2235-2238, Vol 39, No. 10
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

High-throughput screen for detecting antimycobacterial agents

GA Chung, Z Aktar, S Jackson and K Duncan
Glaxo Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom.

A simple, robust assay system which can be used to screen for inhibitors of mycobacterial growth has been developed. A strain of the rapidly growing saprophyte Mycobacterium aurum is used as the test organism. Inhibition of its growth is highly predictive of activity against Mycobacterium tuberculosis, which cannot itself be used in screening because of its growth characteristics and highly infectious nature. The viability of M. aurum in the presence of a test sample is monitored by measuring the uptake of radiolabelled uracil into the cells. In a microtiter plate format, the screen has the potential for testing several thousand samples per day.


This article has been cited by other articles:

  • Rieder, R. J., Zhao, Z., Zavizion, B. (2009). New Approach for Drug Susceptibility Testing: Monitoring the Stress Response of Mycobacteria. Antimicrob. Agents Chemother. 53: 4598-4603 [Abstract] [Full Text]  
  • Gupta, A., Bhakta, S., Kundu, S., Gupta, M., Srivastava, B. S., Srivastava, R. (2009). Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening. J Antimicrob Chemother 64: 774-781 [Abstract] [Full Text]  
  • Ballell, L., Field, R. A., Duncan, K., Young, R. J. (2005). New Small-Molecule Synthetic Antimycobacterials. Antimicrob. Agents Chemother. 49: 2153-2163 [Full Text]  
  • Williams, K. J., Chung, G. A. C., Piddock, L. J. V. (1998). Accumulation of Norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis. Antimicrob. Agents Chemother. 42: 795-800 [Abstract] [Full Text]  
  • Belisle, J. T., Vissa, V. D., Sievert, T., Takayama, K., Brennan, P. J., Besra, G. S. (1997). Role of the Major Antigen of Mycobacterium tuberculosis in Cell Wall Biogenesis. Science 276: 1420-1422 [Abstract] [Full Text]